Safety and Efficacy of Maximally Tolerated RAAS Blockade and Spironolactone Therapy on Urinary Proteinuria and Progression of Type II Diabetic Nephropathy in African Americans and Other Patient Cohorts.
Nephrology, Dialysis, Transplantation, 35(10), 1769-1778. Oxford University Press Nephrology Dialysis Transplantation Bushinsky, D A, Chertow, G M, Cheng, S, Deng, H, Kopyt, N, Martin, K J, Rastogi, A, Ureña-Torres, P, Vervloet, M G & Block, G A 2020, ' One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism ', Nephrology, Dialysis, Transplantation, vol. 35, no. 10, pp. 1769-1778 . https://doi.org/10.1093/ndt/gfz039